Report overview
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics Drugs. This report contains market size and forecasts of Biologic Therapeutics Drugs in global, including the following market information:
Global Biologic Therapeutics Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biologic Therapeutics Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Biologic Therapeutics Drugs companies in 2022 (%)
The global Biologic Therapeutics Drugs market was valued at US$ 331750 million in 2022 and is projected to reach US$ 490710 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
We surveyed the Biologic Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Therapeutics Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Biologic Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Global Biologic Therapeutics Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Biologic Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Global Biologic Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Biologic Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Therapeutics Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biologic Therapeutics Drugs revenues share in global market, 2022 (%)
Key companies Biologic Therapeutics Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Biologic Therapeutics Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Therapeutics Drugs, market overview.
Chapter 2: Global Biologic Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biologic Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
